Skip to main content
Veterinary Medicines

V.H. + H-120 - atenuowany wirus rzekomego pomoru ptaków (choroby Newcastle), szczep VHnie mniej niż 10^6,0 EID50 i nie więcej niż 10^7,49 EID50;- atenuowany wirus zakaźnego zapalenia oskrzeli ptaków, szczep H-120nie mniej niż 10^3,5 EID50 i nie więcej niż 10^4,49 EID50. Liofilizat do sporządzania zawiesiny

Authorised
  • Newcastle disease virus, strain V.H., Live
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live

Product identification

Medicine name:
V.H. + H-120 - atenuowany wirus rzekomego pomoru ptaków (choroby Newcastle), szczep VHnie mniej niż 10^6,0 EID50 i nie więcej niż 10^7,49 EID50;- atenuowany wirus zakaźnego zapalenia oskrzeli ptaków, szczep H-120nie mniej niż 10^3,5 EID50 i nie więcej niż 10^4,49 EID50. Liofilizat do sporządzania zawiesiny
Active substance:
  • Newcastle disease virus, strain V.H., Live
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
Target species:
  • Chicken (hen)
Route of administration:
  • Nebulisation use
  • In drinking water use

Product details

Active substance and strength:
  • Newcastle disease virus, strain V.H., Live
    30903000.00
    50% Embryo Infective Dose
    /
    1.00
    50% Embryo Infective Dose
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
    30903.00
    50% Embryo Infective Dose
    /
    1.00
    50% Embryo Infective Dose
Pharmaceutical form:
  • Lyophilisate for suspension
Withdrawal period by route of administration:
  • Nebulisation use
    • Chicken (hen)
      • All relevant tissues
        0
        day
  • In drinking water use
    • Chicken (hen)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD06
  • QI01AD07
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Phibro Animal Health (Poland) Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Synoptis Industrial Sp. z o.o.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1232
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."